Zepp Health receives a buy rating with a 1-year price target of $21.2, implying 22% upside from $18. Zepp Health posted 78.5% YoY revenue growth in Q3, driven by a shift to own-branded Amazfit products and improved operational efficiencies. Operating breakeven and narrowing net loss signal more sustainable earnings, while a share repurchase program highlights confidence in liquidity.
MILPITAS, Calif.--(BUSINESS WIRE)-- #DiscoverAmazing--Amazfit, a leading global smart wearable brand by Zepp Health (NYSE: ZEPP), today announces the Amazfit Active Max, the newest member of the Amazfit Active family. Built for everyday athletes and anyone looking to elevate their wellness routine, Active Max blends a 1.5″ ultra-bright AMOLED display, up to 25 days of battery life, easy podcast...
Zepp Health makes health wearables such as smartwatches, smart rings, and smart bands with biometric sensors that track the vitals of their users. The stock has climbed by almost 1,100% over the past six months.
Shares of Zepp have corrected ~50% from recent peaks after a sharp YTD spike, providing a near-term buying opportunity. I'm upgrading ZEPP to a 'Buy' rating after a sharp acceleration in Q3 sales to 78% y/y growth, driven by a successful launch of the company's latest T-Rex Pro 3. Q3 sales were held back by a September typhoon and supply constraints on the Helio fitness tracking, pushing out mo...
Zepp Health Corporation ( ZEPP ) Q3 2025 Earnings Call November 4, 2025 8:30 PM EST Company Participants Grace Yujia Zhang - Director of Investor Relations Wang Huang - Founder, Chairman & CEO Leon Cheng Deng - Chief Financial Officer Conference Call Participants Siddharth Rajeev - Fundamental Research Corp. Dylan Chu Yuan Zhu Presentation Operator Hello, ladies and gentlemen. Thank you for sta...
MILPITAS, Calif. , Nov. 4, 2025 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE: ZEPP) today announced its unaudited financial results for the third quarter of 2025.
aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.